Brain-disease focused Cerevance and Takeda Pharmaceutical forged a research collaboration to tackle gastrointestinal disorders that have their roots in the central nervous system.
Omega Therapeutics debuted with a focus on epigenetics, the study of changes in gene expression that do not involve changes to the DNA sequence.
Personal Genome Diagnostics Collaborates with Merck on Global Clinical Trial Evaluating Response to Dual Biomarker Directed Precision Oncology Combination Therapy
Advanced Non-Small Cell Lung Cancer, Assays, Biomarkers, Business, Clinical Trials, Collaborations, Gene Expression, Genomes, Liquid Biopsies, Oncology, Tumor Biopsies, TumorsPersonal Genome Diagnostics Inc. reported that the cancer genomics company’s 500+ gene pan-cancer tumor profiling tissue assay is being used in Merck’s Phase 2 precision oncology KeyImPaCT study of biomarker-directed, pembrolizumab-based combination therapy for advanced non-small-cell lung cancer (KEYNOTE-495).
